BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24721120)

  • 1. Hyperglycemia induces embryopathy, even in the absence of systemic maternal diabetes: an in vivo test of the fuel mediated teratogenesis hypothesis.
    Baack ML; Wang C; Hu S; Segar JL; Norris AW
    Reprod Toxicol; 2014 Jul; 46():129-36. PubMed ID: 24721120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy.
    Yang P; Zhao Z; Reece EA
    Am J Obstet Gynecol; 2008 Jan; 198(1):130.e1-7. PubMed ID: 18166327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal Hyperglycemia Directly and Rapidly Induces Cardiac Septal Overgrowth in Fetal Rats.
    Gordon EE; Reinking BE; Hu S; Yao J; Kua KL; Younes AK; Wang C; Segar JL; Norris AW
    J Diabetes Res; 2015; 2015():479565. PubMed ID: 26064981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic embryopathy and fuel-mediated organ teratogenesis: lessons from animal models.
    Freinkel N
    Horm Metab Res; 1988 Aug; 20(8):463-75. PubMed ID: 3053387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The increased activity of a transcription factor inhibits autophagy in diabetic embryopathy.
    Xu C; Chen X; Reece EA; Lu W; Yang P
    Am J Obstet Gynecol; 2019 Jan; 220(1):108.e1-108.e12. PubMed ID: 30312583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taurine attenuates maternal and embryonic oxidative stress in a streptozotocin-diabetic rat model.
    Shivananjappa MM; Muralidhara
    Reprod Biomed Online; 2012 May; 24(5):558-66. PubMed ID: 22414371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary myo-inositol therapy in hyperglycemia-induced embryopathy.
    Khandelwal M; Reece EA; Wu YK; Borenstein M
    Teratology; 1998 Feb; 57(2):79-84. PubMed ID: 9562680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid.
    Goldman AS; Baker L; Piddington R; Marx B; Herold R; Egler J
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8227-31. PubMed ID: 3934670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental mechanisms of diabetic embryopathy and strategies for developing therapeutic interventions.
    Zhao Z; Reece EA
    J Soc Gynecol Investig; 2005 Dec; 12(8):549-57. PubMed ID: 16325743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic embryopathy. Studies with animal and in vitro models.
    Eriksson UJ; Borg LA; Forsberg H; Styrud J
    Diabetes; 1991 Dec; 40 Suppl 2():94-8. PubMed ID: 1748275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant patterns of cellular communication in diabetes-induced embryopathy. I. Membrane signalling.
    Reece EA; Ma XD; Wu YK; Dhanasekaran D
    J Matern Fetal Neonatal Med; 2002 Apr; 11(4):249-53. PubMed ID: 12375679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disturbed intracellular calcium homeostasis in neural tube defects in diabetic embryopathy.
    Zhao Z; Cao L; Hernández-Ochoa E; Schneider MF; Reece EA
    Biochem Biophys Res Commun; 2019 Jun; 514(3):960-966. PubMed ID: 31092336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifactorial basis of the syndrome of diabetic embryopathy.
    Reece EA; Homko CJ; Wu YK
    Teratology; 1996 Oct; 54(4):171-82. PubMed ID: 9122886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronization of the factors critical for diabetic teratogenesis: an in vitro model.
    Reece EA; Wiznitzer A; Homko CJ; Hagay Z; Wu YK
    Am J Obstet Gynecol; 1996 Apr; 174(4):1284-8. PubMed ID: 8623857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam.
    Singh CK; Kumar A; Hitchcock DB; Fan D; Goodwin R; LaVoie HA; Nagarkatti P; DiPette DJ; Singh US
    Mol Nutr Food Res; 2011 Aug; 55(8):1186-96. PubMed ID: 21254394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of differential gene expression profiles in diabetic embryopathy using DNA microarray analysis.
    Reece EA; Ji I; Wu YK; Zhao Z
    Am J Obstet Gynecol; 2006 Oct; 195(4):1075-80. PubMed ID: 17000240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of c-Jun N-terminal kinases activation in diabetic embryopathy.
    Yang P; Zhao Z; Reece EA
    Biochem Biophys Res Commun; 2007 Jun; 357(3):749-54. PubMed ID: 17449011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of the essential role of protein kinase C isoforms in hyperglycemia-induced embryonic malformations.
    Zhiyong Zhao ; Wu YK; Reece EA
    Reprod Sci; 2008 Apr; 15(4):349-56. PubMed ID: 18497343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PGE2 prevents anomalies induced by hyperglycemia or diabetic serum in mouse embryos.
    Goto MP; Goldman AS; Uhing MR
    Diabetes; 1992 Dec; 41(12):1644-50. PubMed ID: 1446806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOD1 suppresses maternal hyperglycemia-increased iNOS expression and consequent nitrosative stress in diabetic embryopathy.
    Weng H; Li X; Reece EA; Yang P
    Am J Obstet Gynecol; 2012 May; 206(5):448.e1-7. PubMed ID: 22425406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.